Clozapine-associated Infection
NCT05919550 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26815616
Last updated 2023-06-26
Summary
perform a study in VigiBase® to assess if clozapine was associated with an over-reporting of infections and to characterize those infections. The investigators also decided to assess the dose dependency associated with those infections.
Conditions
Interventions
- DRUG
-
search for a clozapine intake
search for a clozapine intake
Sponsors & Collaborators
-
University Hospital, Caen
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-11
- Primary Completion
- 2023-04-11
- Completion
- 2023-04-11
- FDA Drug
- Yes
Countries
- France
Study Locations
More Related Trials
-
Minocycline Augmentation to Clozapine
NCT02124811 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia
NCT00169065 ·Status: COMPLETED ·Phase: PHASE4
-
Clozapine and Haematologic Malignancies: Observational and Retrospective Study Using the WHO Pharmacovigilance Database
NCT04074213 ·Status: UNKNOWN
-
Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease
NCT00004826 ·Status: COMPLETED ·Phase: NA
-
Clozapine Versus Olanzapine as Treatment for Comorbid Psychotic Disorder and Substance Use Disorder
NCT03857581 ·Status: UNKNOWN ·Phase: PHASE4
-
Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder
NCT00501618 ·Status: COMPLETED ·Phase: PHASE4
-
Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia
NCT00179231 ·Status: COMPLETED ·Phase: NA
-
An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
NCT00510211 ·Status: COMPLETED
-
A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-04958242 In Psychiatrically Stable Subjects With Schizophrenia
NCT01518894 ·Status: COMPLETED ·Phase: PHASE1
-
Characterizing Response to Antipsychotics in Schizophrenia
NCT06159322 ·Status: RECRUITING
-
Clozapine for Treatment-Resistant Mania
NCT00029458 ·Status: COMPLETED ·Phase: PHASE2
-
Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)
NCT01190267 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults
NCT01429740 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder
NCT00480571 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia
NCT00485823 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia
NCT00345033 ·Status: COMPLETED ·Phase: PHASE4
-
Dissociative Disorders in Obesity (Dissobe)
NCT05081778 ·Status: COMPLETED
-
A Study for Patients With Schizophrenia
NCT00520923 ·Status: COMPLETED ·Phase: PHASE2
-
Olanzapine Treatment of Patients With Bipolar I Disorder
NCT00510146 ·Status: COMPLETED ·Phase: PHASE3
-
Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia
NCT02639702 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis
NCT04529226 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Polypharmacy in Clozapine-resistant Schizophrenia
NCT00918021 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment
NCT00191555 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Olanzapine in Participants With Bipolar Disorder.
NCT07263191 ·Status: RECRUITING
-
Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment
NCT00337350 ·Status: COMPLETED ·Phase: PHASE4